<SEC-DOCUMENT>0001004878-17-000109-index.html : 20170502
<SEC-HEADER>0001004878-17-000109.hdr.sgml : 20170502
<ACCEPTANCE-DATETIME>20170502163012
ACCESSION NUMBER:		0001004878-17-000109
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20170430
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170502
DATE AS OF CHANGE:		20170502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		17805463

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8kitem101skkwrnt5-17.txt
<DESCRIPTION>FORM 8-K ITEM 1.01 RE SERIES KK WARRANTS
<TEXT>
Document 1 - file: form8kitem101skkwrnt5-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>form8kitem101ex11may-17.txt
<DESCRIPTION>EXHIBIT 1.1 ENGAGEMENT AGREEMENT
<TEXT>
Document 2 - file: form8kitem101ex11may-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>3
<FILENAME>form8kitem101ex4qmay-17.txt
<DESCRIPTION>EXHIBIT 4(Q) FORM OF WARRANT (SERIES KK)
<TEXT>
Document 3 - file: form8kitem101ex4qmay-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>4
<FILENAME>form8kitem101ex4rmay-17.txt
<DESCRIPTION>EXHIBIT 4(R) PLACEMENT AGENT WARRANT (SERIES LL)
<TEXT>
Document 4 - file: form8kitem101ex4rmay-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>5
<FILENAME>form8kitem101ex5may-17.txt
<DESCRIPTION>EXHIBIT 5 OPINION LETTER
<TEXT>
Document 5 - file: form8kitem101ex5may-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>6
<FILENAME>form8kitem101ex10sssmay-17.txt
<DESCRIPTION>EXHIBIT 10 (SSS) SECURITIES PURCHASE AGREEMENT
<TEXT>
Document 6 - file: form8kitem101ex10sssmay-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>7
<FILENAME>form8kitem101ex23may-17.txt
<DESCRIPTION>EXHIBIT 23 ATTORNEY'S CONSENT
<TEXT>
Document 7 - file: form8kitem101ex23may-17.txt

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>8
<FILENAME>form8kitem101ex99may-17.txt
<DESCRIPTION>EXHIBIT 99 PRESS RELEASE
<TEXT>
Document 8 - file: form8kitem101ex99may-17.txt

</DOCUMENT>
</SEC-DOCUMENT>